Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
about
Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Metformin use and cervical cancer risk in female patients with type 2 diabetesMetformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.Metformin and lung cancer risk in patients with type 2 diabetes mellitus.Sitagliptin and oral cancer risk in type 2 diabetes patients.
P2860
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
@en
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
@nl
type
label
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
@en
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
@nl
prefLabel
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
@en
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
@nl
P2860
P921
P356
P1433
P1476
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
@en
P2093
Chin-Hsiao Tseng
P2860
P304
62687-62696
P356
10.18632/ONCOTARGET.10507
P407
P577
2016-07-09T00:00:00Z